Revenue | ₹214.20Cr |
Net Profits | ₹23.47Cr |
Net Profit Margins | 10.96% |
SMS Pharmaceuticals Ltd’s revenue jumped 22.07% since last year same period to ₹214.20Cr in the Q3 2025-2026. On a quarterly growth basis, SMS Pharmaceuticals Ltd has generated -12.16% fall in its revenue since last 3-months.
SMS Pharmaceuticals Ltd’s net profit jumped 28.67% since last year same period to ₹23.47Cr in the Q3 2025-2026. On a quarterly growth basis, SMS Pharmaceuticals Ltd has generated -7.27% fall in its net profits since last 3-months.
SMS Pharmaceuticals Ltd’s net profit margin jumped 5.41% since last year same period to 10.96% in the Q3 2025-2026. On a quarterly growth basis, SMS Pharmaceuticals Ltd has generated 5.57% jumped in its net profit margins since last 3-months.
The revenue for SMS Pharmaceuticals Ltd in the Q3 results 2025 was ₹214.20Cr.
The net profit for SMS Pharmaceuticals Ltd in the Q3 results 2025 was ₹23.47Cr.
The net profit margin for SMS Pharmaceuticals Ltd in the Q3 results 2025 was 10.96%.
The revenue for SMS Pharmaceuticals Ltd in the Q3 results 2024 was ₹175.48Cr.
The net profit for SMS Pharmaceuticals Ltd in the Q3 results 2024 was ₹18.24Cr.
The net profit margin for SMS Pharmaceuticals Ltd in the Q3 results 2024 was 10.39%.